| Space Exploration Technologies Corp | 1.4M | US$239M | 36.0% |
| Aktis Oncology, Inc. | 3.07M | US$99M | 14.9% |
| Cullinan Therapeutics, Inc. | 1.54M | US$28M | 4.2% |
| Larimar Therapeutics, Inc. | 9.16M | US$27.9M | 4.2% |
| Nuveen Churchill Direct Lending Corp. | 2.14M | US$26.6M | 4.0% |
| Maplight Therapeutics, Inc. | 730K | US$26.2M | 3.9% |
| Capital One Financial Corporation | 120K | US$24M | 3.6% |
| Blue Owl Capital Corporation | 2.05M | US$22.2M | 3.3% |
| Deep Fission, Inc. | 1.33M | US$14.7M | 2.2% |
| Dell Technologies Inc. | 32,961 | US$14.2M | 2.1% |
| Holley Inc. | 4.38M | US$11.2M | 1.7% |
| Eyepoint, Inc. | 763K | US$10.9M | 1.6% |
| Sagimet Biosciences Inc. - Series A | 1.26M | US$9.74M | 1.5% |
| Corvus Pharmaceuticals, Inc. | 609K | US$9.09M | 1.4% |
| Artiva Biotherapeutics, Inc. | 875K | US$8.48M | 1.3% |
| Compass Therapeutics, Inc. | 3.62M | US$7.94M | 1.2% |
| Conduent Incorporated | 5.04M | US$7.35M | 1.1% |
| Rhythm Pharmaceuticals, Inc. | 61,455 | US$6.82M | 1.0% |
| Ultragenyx Pharmaceutical Inc. | 183K | US$6.1M | 0.92% |
| Palvella Therapeutics, Inc. | 36,259 | US$5.54M | 0.83% |
| Imagenebio, Inc. | 918K | US$5.41M | 0.81% |
| Viridian Therapeutics, Inc. | 260K | US$4.78M | 0.72% |
| Immix Biopharma, Inc. | 438K | US$4.51M | 0.68% |
| Oric Pharmaceuticals, Inc. | 400K | US$4.33M | 0.65% |
| Lenz Therapeutics, Inc. | 757K | US$4.3M | 0.65% |
| Aquestive Therapeutics, Inc. | 943K | US$3.92M | 0.59% |
| Starwood Property Trust Inc. | 196K | US$3.22M | 0.48% |
| Evommune, Inc. | 180K | US$2.39M | 0.36% |
| Eledon Pharmaceuticals, Inc. | 567K | US$2.23M | 0.34% |
| Cabaletta Bio, Inc. | 715K | US$2.22M | 0.33% |
| Chime Financial, Inc. | 89,878 | US$1.84M | 0.28% |
| Context Therapeutics Inc. | 2.93M | US$1.63M | 0.24% |
| Ww International, Inc. | 84,399 | US$1.35M | 0.20% |
| Marker Therapeutics, Inc. | 554K | US$815K | 0.12% |
| Cybin, Inc. | 59,911 | US$396K | 0.06% |
| Fold Holdings, Inc. | 857K | US$385K | 0.06% |
| Piper Sandler Companies | 2,428 | US$176K | 0.03% |
| Celcuity Inc. | 1,249 | US$131K | 0.02% |
| Energy Transfer Lp | 5,326 | US$102K | 0.02% |
| Caris Life Sciences, Inc. | 4,711 | US$83,950 | 0.01% |
| Vodafone Group Public Limited Company | 5,371 | US$71,005 | 0.01% |
| Aeon Biopharma, Inc. | 42,353 | US$30,494 | <0.01% |
| Shf Holdings, Inc. | 75,897 | US$18,215 | <0.01% |
| Katapult Holdings, Inc. | 5,421 | US$5,373 | <0.01% |
| Cardinal Health, Inc. | 0 | US$0 | 0.00% |
| Enterprise Products Partners L.p. | 0 | US$0 | 0.00% |
| Alpha Modus Holdings, Inc. | 0 | US$0 | 0.00% |
| Cid Holdco, Inc. | 0 | US$0 | 0.00% |
| Civeo Corporation (canada) | 0 | US$0 | 0.00% |
| Gohealth, Inc. | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ovid Therapeutics Inc. | 0 | US$0 | 0.00% |
| Pliant Therapeutics, Inc. | 0 | US$0 | 0.00% |